8 studies found for:    "Columbia University" AND "HCV" | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant
Conditions: Hepatitis C Virus;   Liver Transplant Recipient;   Recurrent Fibrosis
Interventions: Drug: Rifaximin;   Drug: Placebo
2 Recruiting Boceprevir in End Stage Renal Disease (ESRD)
Conditions: Hepatitis C Infection;   End Stage Renal Disease
Interventions: Drug: Peginterferon alfa 2b;   Drug: Peginterferon alfa 2a;   Drug: Ribavirin;   Drug: Boceprevir
3 Recruiting An Observational Study of Hepatitis C Virus in Pregnancy
Condition: Hepatitis C
Intervention:
4 Recruiting Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Conditions: Hepatitis C Infection;   Viruses;   Hepatocellular Carcinoma;   Hepatitis, Viral, Human;   Liver Cirrhosis
Intervention: Biological: Civacir® 10%
5 Recruiting A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
Conditions: Liver Fibrosis;   Hepatic Fibrosis
Intervention: Drug: IDN-6556
6 Recruiting Adult-to-Adult Living Donor Transplant Cohort Study
Conditions: Liver Diseases;   Hepatocellular Cancer;   End Stage Liver Disease;   Hepatitis C;   Liver Cirrhosis
Intervention:
7 Recruiting Everolimus Post Orthotopic Liver Transplant
Condition: Liver Transplantation
Interventions: Drug: Everolimus;   Drug: Standard Tacrolimus
8 Recruiting S1204, Viral Screening in Newly Diagnosed Cancer Patients
Condition: Cancer
Intervention:

Indicates status has not been verified in more than two years